MilliporeSigma’s New Microbial Bioburden Testing System Offers Enhanced Results and Increased Productivity
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
MilliporeSigma’s latest innovation, the Milliflex Oasis System, offers enhanced benefits for pharmaceutical bioburden and water testing. It has 96 new features to increase result reliability and traceability while streamlining the bioburden testing workflow, the company reports.
The benefits of the new system include:
- Operator-independent handling steps, improved touch-free membrane transfer with color-coded components for increased result reliability
- 50% faster filtration time compared with previous product generation
- Scalable hardware for high throughput
- Reduced decontamination and maintenance time for optimized productivity
- 2-dimensional codes and labels on primary and secondary packaging, on each funnel and media plate, for traceability and regulation compliance
The system also offers an all-in-one filtration solution with sterilized, ready-to-use filtration units and pharmacopeia-compliant media for comfort and peace of mind for water and bioburden testing, according to the company. MilliporeSigma launched the Milliflex Oasis System on Jan. 29, 2020.
Source: MilliporeSigma
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
